Vesicular Monoamine Transporter 2 Inhibitors
DBCAT004435Pharmacologic class
A DrugBank category of 3 drugs. 3 of them are approved.
What you can answer from here — as of November 29, 2022
Which targets do Vesicular Monoamine Transporter 2 Inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account